54X-20296-63655
6 vaccinations
12 coded responses
58 check-ins
9 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 193 / PA
- Registered
- 2021-02-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-05
Dose 1 — Moderna
-
2021-02-06
Registered in v-safe
- 2021-02-06
-
2021-02-07
Survey response — days 1–6 daily, dose 1MedDRA: Dysgeusia — Feeling: GoodFree text: A faint metallic taste in my mouth.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-08
- 2021-02-09
-
2021-02-10
Survey response — days 1–6 daily, dose 1MedDRA: Dysgeusia — Feeling: GoodFree text: Still have a slight metallic taste in my mouth.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-11
-
2021-02-12
Survey response — day 7, dose 1MedDRA: Dysgeusia — Feeling: GoodFree text: Still have slight metallic taste in my mouth- mildMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-19
- 2021-02-26
-
2021-03-05
Dose 2 — Moderna
- 2021-03-05
-
2021-03-06
Survey response — days 1–6 daily, dose 2MedDRA: Dysgeusia — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: My mouth started tasting like metal about 8 hours after the shot. Last time it lasted for 10 daysMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-07
Survey response — days 1–6 daily, dose 2MedDRA: Dysgeusia — Feeling: GoodFree text: Still have a metallic taste in my mouth.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-08
Survey response — days 1–6 daily, dose 2MedDRA: Dysgeusia — Feeling: GoodFree text: Slight metallic taste in my mouthMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-09
Survey response — days 1–6 daily, dose 2MedDRA: Dysgeusia — Feeling: GoodFree text: Slight metallic taste in my mouthMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-10
Survey response — days 1–6 daily, dose 2MedDRA: Dysgeusia — Feeling: GoodFree text: Slight metallic taste in my mouthMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-11
- 2021-03-12
- 2021-03-19
- 2021-03-26
- 2021-04-02
- 2021-04-09
- 2021-04-16
- 2021-06-04
- 2021-09-03
-
2021-10-22
Dose 3 — Moderna
- 2021-10-28
-
2021-10-29
Survey response — day 7, dose 3MedDRA: Diabetes mellitus, Pre-existing disease — Feeling: GoodFree text: I'm a type 1 diabetic and my insulin needs went up after my booster. They are just returning to normal.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-05
- 2021-11-12
- 2021-11-19
- 2021-11-26
- 2021-12-03
- 2022-01-21
-
2022-04-01
Dose 4 — Moderna
- 2022-04-18
- 2022-04-22
- 2022-04-29
- 2022-05-06
- 2022-05-13
- 2022-07-01
-
2022-09-06
Dose 5 — Moderna
- 2022-09-17
- 2022-09-20
- 2022-09-27
- 2022-10-04
- 2022-10-11
- 2022-10-18
- 2022-12-06
-
2023-03-07
Survey response — 6 months, dose 5MedDRA: Fatigue, Influenza virus test negative, Pyrexia, Red blood cell sedimentation rate increased, SARS-CoV-2 test negative — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-03-07
Report sent to call center — 6 months, dose 5Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-03-08
Call successfulNot applicable - Accidental Reporting
-
2023-05-08
Dose 6 — Pfizer-BioNTech
- 2023-05-08
-
2023-05-09
Health check-in — days 1–6 daily, dose 6Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2023-05-10
Survey response — days 1–6 daily, dose 6MedDRA: Blood glucose increased — Feeling: FairMedDRA releases: 2024-11
- 2023-05-11
-
2023-05-12
Survey response — days 1–6 daily, dose 6MedDRA: Lung neoplasm malignant, Surgery — Feeling: Fair · Fatigue or tirednessMedDRA releases: 2024-11
- 2023-05-14
- 2023-05-15
- 2023-05-22
- 2023-05-29
- 2023-06-05
- 2023-06-12
- 2023-06-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-05 | Moderna | |
| 2 | 2021-03-05 | Moderna | |
| 3 | 2021-10-22 | Moderna | No |
| 4 | 2022-04-01 | Moderna | No |
| 5 | 2022-09-06 | Moderna | No |
| 6 | 2023-05-08 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 3 — days 1–6 daily, dose 1
Systemic reaction (other): A faint metallic taste in my mouth.
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): Still have a slight metallic taste in my mouth.
Release 4 — day 7, dose 1
Systemic reaction (other): Still have slight metallic taste in my mouth- mild
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): My mouth started tasting like metal about 8 hours after the shot. Last time it lasted for 10 days
Systemic reaction (other): Still have a metallic taste in my mouth.
Systemic reaction (other): Slight metallic taste in my mouth
Systemic reaction (other): Slight metallic taste in my mouth
Systemic reaction (other): Slight metallic taste in my mouth
Release 10 — day 7, dose 3
Systemic reaction (other): I'm a type 1 diabetic and my insulin needs went up after my booster. They are just returning to normal.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
| SD | Influenza virus test negative | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Red blood cell sedimentation rate increased | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Blood glucose increased | · | · | ✓ |
| SRO | Diabetes mellitus | · | · | ✓ |
| SRO | Dysgeusia | ✓ | ✓ | ✓ |
| SRO | Lung neoplasm malignant | · | · | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
| SRO | Surgery | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release